Company intelligence

WhiteLab Genomics

BiotechSee connections →

Recent changes

  1. Oct 7, 2026Raised $26M Series B Pulse 2.0
  2. Oct 7, 2026WhiteLab Genomics Raises $26M to Design Gene Therapies With AI Pulse story

Funding History

1 event · sources dated per row
DateEventAmountValuationInvestorsSource
Oct 7, 2026Series B$26M—
Omnes CapitalunverifiedAVPYaday HealthBlast ClubDebiopharm Innovation Fund
Pulse 2.0

Investors

Omnes Capital

Latest Pulse

  1. WhiteLab Genomics Raises $26M to Design Gene Therapies With AIParis-founded WhiteLab Genomics raised a $26 million Series B led by AVP to expand ALFRED, its AI platform for designing delivery systems for cell and gene therapies.→

Coverage Timeline

newest first
  1. Oct 7, 2026FUNDINGWhiteLab Genomics Raises $26M to Design Gene Therapies With AI$26M Series B→

All Coverage

FUNDING

WhiteLab Genomics Raises $26M to Design Gene Therapies With AI

Illustration for: WhiteLab Genomics Raises $26M to Design Gene Therapies With AI
FUNDING$26M Series B

WhiteLab Genomics Raises $26M to Design Gene Therapies With AI

Paris-founded WhiteLab Genomics raised a $26 million Series B led by AVP to expand ALFRED, its AI platform for designing delivery systems for cell and gene therapies.

DEEP DIVE

Related Companies

Same sector
Scribe TherapeuticsAttovia TherapeuticsApnimedRetension PharmaceuticalsBraveheart BioEli Lilly

WhiteLab Genomics FAQ

Who are WhiteLab Genomics's investors?

WhiteLab Genomics's investors include Omnes Capital.

Sources & methodologyshow
Where these figures come from

Figures are labelled Reported (a source states it), Estimated, Derived (computed from other facts) or Rumored (in talks / unconfirmed). Rumors never replace a confirmed figure. Each figure keeps its own as-of date; history is preserved rather than overwritten.

How we verify data · Suggest a correction